comparemela.com
Home
Live Updates
Riccardo Lencioni - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Riccardo lencioni - Page 1 : comparemela.com
TACE Plus Durvalumab and Bevacizumab Could Alter SOC in Embolization-Eligible, Unresectable HCC
Riccardo Lencioni, MD, discusses how TACE, durvalumab, and bevacizumab, could represent a new standard of care in embolization-eligible HCC.
Italy
Riccardo-lencioni
Department-of-surgery
Cancers-symposium
Critical-area-pathology
Riccardo-lencioni
D
Chemoembolization-tace-
Urvalumab-imfinzi-
Nd-bevacizumab-avastin-
Hepatocellular-carcinoma
Hcc
Durvalumab Plus Bevacizumab Improves TACE Outcomes in HCC
A new study showed improved progression-free survival when systemic therapy is added to TACE for HCC. Overall survival outcomes are pending.
United-states
Italy
New-york
American
Josep-llovet
Riccardo-lencioni
University-of-pisa
American-society-of-clinical-oncology
American-society
Clinical-oncology
Mount-sinai-hospital
Hepatocellular-carcinoma-hcc-liver-cancer-of-the
Highlights from the Gastrointestinal and Genitourinary Cancer Conferences
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
United-states
American
Riccardo-lencioni
Michiels-van
Drug-administration
American-society
Clinical-oncology
Gastrointestinal-cancers-symposium
Genitourinary-cancers
Gastrointestinal-cancers
Der-heijden
Neal-shore
Imfinzi, Avastin, TACE May 'Set a New Standard of Care' in Liver Cancer
Adding Imfinzi and Avastin to transarterial chemoembolization led to a 23% reduction in the risk of progression or death in patients with liver cancer.
Italy
Japan
Imfinzi-avastin
Riccardo-lencioni
Department-of-surgery
Critical-area-pathology
Asco-gastrointestinal-cancers-symposium
Liver-cancer
New Standard for Unresectable Hepatocellular Carcinoma?
Adding durvalumab and bevacizumab to transarterial chemoembolization almost doubles PFS
Italy
Barcelona
Comunidad-autonoma-de-cataluna
Spain
New-york
United-states
Josepm-llovet
Charles-bankhead
Riccardo-lencioni
University-of-barcelona
University-of-pisa
Icahn-school-of-medicine-at-mount-sinai
vimarsana © 2020. All Rights Reserved.